(Q67699496)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716098%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

FK-506 and cyclosporin A: selective inhibition of calcium ionophore-induced polymorphonuclear leukocyte degranulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716098%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

FK-506 and cyclosporin a: Selective inhibition of calcium ionophore-induced polymorphonuclear leukocyte degranulation (English)

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

6 November 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

6 November 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

6 November 2022

author name string

M. J. Forrest

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716098

6 November 2022

M. E. Jewell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716098

6 November 2022

G. C. Koo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716098

6 November 2022

N. H. Sigal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716098

6 November 2022

language of work or name

English

0 references

publication date

1 August 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716098%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

22 August 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1716098

full work available at URL

6 November 2022

https://api.elsevier.com/content/article/PII:0006295291902576?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

https://api.elsevier.com/content/article/PII:0006295291902576?httpAccept=text/plain

6 November 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

6 November 2022

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716098%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716098%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

1221-1228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716098%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716098%20AND%20SRC:MED&resulttype=core&format=json

Cyclosporin A in patients receiving renal allografts from cadaver donors

17 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Cyclosporin A for the treatment of graft-versus-host disease in man

6 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

FK 506 for liver, kidney, and pancreas transplantation

6 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes

6 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription

6 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Induction of Interleukin 2 Messenger RNA Inhibited by Cyclosporin A

6 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Cyclophilin: a specific cytosolic binding protein for cyclosporin A

6 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

FK-506, a potent novel immunosuppressive agent, binds to a cytosolic protein which is distinct from the cyclosporin A-binding protein, cyclophilin

6 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

6 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin

6 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins

6 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression

6 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes

6 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Cyclosporine and human neutrophil function

6 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Cyclosporin A inhibits the release of histamine and peptide leukotriene C4 from human lung mast cells

6 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Inhibitory effect of cyclosporin A on histamine release from human leukocytes and rat mast cells

6 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin

6 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

6 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

An enzyme-linked immunoassay (ELISA) for measurement of lactoferrin

6 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Studies on glucosaminidase. 3. Testicular N-acetyl-beta-glucosaminidase and N-acetyl-beta-galactosaminidase

6 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

6 November 2022

The neutrophil

26

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro

6 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Bioregulation of lysosomal enzyme secretion from human neutrophils: roles of guanosine 3':5'-monophosphate and calcium in stimulus-secretion coupling

6 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Transport of sodium, potassium, and calcium across rabbit polymorphonuclear leukocyte membranes. Effect of chemotactic factor

6 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Inhibition of the immune response by rapamycin, a new antifungal antibiotic

6 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin

6 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Calcium and T lymphocyte activation

6 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Cyclosporine does not prevent cytoplasmic calcium changes associated with lymphocyte activation.

6 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Inhibition of taurocholate transport by cyclosporin A in cultured rat hepatocytes

6 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Cyclosporin A augments vasoconstrictor-induced rise in intracellular free calcium in rat renal mesangial cells

6 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Mechanism of cyclosporin A-induced inhibition of prostacyclin synthesis by macrophages

6 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

In vitro toxicity assessment of cyclosporin A and its analogs in a primary rat hepatocyte culture model

6 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Biochemical characterization of the inhibitory effect of CsA on cytolytic T lymphocyte effector functions

6 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

The effect of calcium and pH on the anaphylactic reaction

6 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

Induction of calcium flux across the rat mast cell membrane by bridging IgE receptors

6 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90257-6

6 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716098%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference